{"TopicDetails": {"type": 0, "ccm2Id": 44835205, "cftId": 0, "identifier": "EU4H-2022-PJ-07", "title": "Call for proposals to support Member States and other relevant actors to implement relevant results of innovative public health research in relation to vaccination against COVID-19", "publicationDateLong": 1644883200000, "callIdentifier": "EU4H-2022-PJ", "callTitle": "Action Grants 2022 - first wave", "callccm2Id": 44774006, "allowPartnerSearch": true, "workProgrammepart": {"id": 6515, "ccm_id": 45114455, "wp_part": "EU4H-2022", "wp_year": "EU4H-2022", "wp_title": "EU4H-2022"}, "frameworkProgramme": {"id": 43332642, "abbreviation": "EU4H", "description": "EU4 Health Programme (EU4H)"}, "programmeDivision": [{"id": 43332657, "abbreviation": "Health", "description": "Improving and fostering health in the Union to reduce the burden of communicable and non-communicable diseases"}, {"id": 43332653, "abbreviation": "EU4H-1", "description": "EU4H-1"}], "topicMGAs": [], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "EU4H-PJG EU4H Project Grants", "typeOfMGA": [{"id": 43326018, "abbreviation": "EU4H-AG", "description": "EU4H Action Grant Budget-Based"}]}], "plannedOpeningDate": "22 February 2022", "submissionProcedure": {"id": 31094504, "abbreviation": "single-stage", "description": "single-stage"}, "deadlineDates": ["24 May 2022"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3382182": [{"action": "EU4H-2022-PJ-08 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "22 February 2022", "deadlineModel": "single-stage", "deadlineDates": ["24 May 2022"], "budgetYearMap": {"2022": 300000}, "budgetTopicActionMap": {}}], "3382184": [{"action": "EU4H-2022-PJ-05 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "22 February 2022", "deadlineModel": "single-stage", "deadlineDates": ["24 May 2022"], "budgetYearMap": {"2022": 4000000}, "budgetTopicActionMap": {}}], "3382186": [{"action": "EU4H-2022-PJ-04 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "22 February 2022", "deadlineModel": "single-stage", "deadlineDates": ["24 May 2022"], "budgetYearMap": {"2022": 1000000}, "budgetTopicActionMap": {}}], "3382188": [{"action": "EU4H-2022-PJ-01 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "22 February 2022", "deadlineModel": "single-stage", "deadlineDates": ["24 May 2022"], "budgetYearMap": {"2022": 30000000}, "budgetTopicActionMap": {}}], "3382190": [{"action": "EU4H-2022-PJ-02 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "22 February 2022", "deadlineModel": "single-stage", "deadlineDates": ["24 May 2022"], "budgetYearMap": {"2022": 5000000}, "budgetTopicActionMap": {}}], "3382192": [{"action": "EU4H-2022-PJ-07 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "22 February 2022", "deadlineModel": "single-stage", "deadlineDates": ["24 May 2022"], "budgetYearMap": {"2022": 30000000}, "budgetTopicActionMap": {}}], "3382194": [{"action": "EU4H-2022-PJ-06 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "22 February 2022", "deadlineModel": "single-stage", "deadlineDates": ["24 May 2022"], "budgetYearMap": {"2022": 29000000}, "budgetTopicActionMap": {}}], "3382196": [{"action": "EU4H-2022-PJ-03 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "22 February 2022", "deadlineModel": "single-stage", "deadlineDates": ["24 May 2022"], "budgetYearMap": {"2022": 8000000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2022"]}, "description": "<SPAN class=\"topicdescriptionkind\">ExpectedOutcome</SPAN>:<p><strong><span><span><span style=\"color:black\">Background and policy context</span></span></span></strong></p><p><span><span><span style=\"color:black\">The COVID-19 pandemic created a need for fast vaccination of entire populations in Member States, which was a challenge of historic dimensions for many countries, as it required a multitude of steps to be taken successfully. These range from the design of vaccination plans, to the set-up of appropriate infrastructure and easily accessible, sufficiently resourced vaccination services, to communication and outreach activities to ensure high uptake of the vaccines, including activities to address vaccine hesitancy and disinformation on related risks. </span></span></span></p><p><span><span><span style=\"color:black\">The novelty of the vaccines to be administered and the pandemic context made the task even more demanding. Hence, there is a need to gain efficiency and develop strategies in terms of large-scale vaccination for other diseases as well. Large-scale vaccination could contribute to enhanced catch-up vaccination in the context of routine vaccination programmes rolled out in the Member States that may have been interrupted or delayed during the COVID-19 health crisis. </span></span></span></p><p><span><span><span style=\"color:black\">This action supports the policy priority to respond to the COVID-19 crisis and implements the EU4Health Programme\u2019s general objective of protecting people in the Union from serious cross-border threats to health (Article 3, point (b)) through the specific objectives defined in Article 4, points (a) and (b), of Regulation (EU) 2021/522.</span></span></span></p>\n<SPAN class=\"topicdescriptionkind\">Objective</SPAN>:<p><strong><span><span><span style=\"color:black\">Objectives pursued </span></span></span></strong></p><p><span><span><span style=\"color:black\">The action aims to support Member States and relevant stakeholders to implement the results of recent and relevant research in relation to vaccination against COVID-19. </span></span></span></p><p><strong><span><span><span style=\"color:black\">Description of the activities to be funded under this topic</span></span></span></strong></p><p><span><span><span style=\"color:black\">The action should cover: </span></span></span></p><p><span><span><span style=\"color:black\">a) mapping public health evidence and research results on COVID-19 large-scale vaccination that could be relevant for uptake, including findings, from Member States and outside of the Union; </span></span></span></p><p><span><span><span style=\"color:black\">b) identifying challenges and assess the feasibility to implement solutions in Member States, based on the mapping and taking country-specific factors into account; </span></span></span></p><p><span><span><span style=\"color:black\">c) developing implementation plans and pilot activities to respond to the current pandemic context or future health crises, or to optimise current routine vaccination practices, including catch-up vaccination; </span></span></span></p><p><span><span><span style=\"color:black\">d) implementing the pilot activities in volunteering Member States including the activities identified as potentially most effective (e.g. training programmes for health professionals, awareness-raising campaigns to tackle vaccine hesitancy, health preparedness training programmes, infrastructure initiatives, dedicated events for the exchange of good practices, risk communication and community engagement etc.);</span></span></span></p><p><span><span><span style=\"color:black\">e) identifying successful pilot activities and, based on these, develop a robust sustainability plan for continued implementation and toolkits and recommendations for upscaling in other Member States.</span></span></span></p>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p><strong><span><span><span style=\"color:black\">Expected results and impact</span></span></span></strong></p><p><span><span><span style=\"color:black\">The action is expected to deliver an inventory of relevant innovative public health research on COVID-19 large-scale vaccination and implement plans in relevant Member States taking into account feasibility and country specific factors. This will result, based on pilot projects implemented in several Member States and, after assessment, in the development of sustainability plans and toolkits and recommendations. </span></span></span></p><p><strong><span><span><span style=\"color:black\">Specific mandatory deliverables and/or milestones</span></span></span></strong></p><p><span><span><span style=\"color:black\">These activities are expected to increase efficiency in terms of large-scale vaccination, making the best possible use of research results to increase uptake of COVID-19 vaccines and/or other vaccines covered by routine vaccination programmes. </span></span></span></p><p><span><span><span style=\"color:black\">A project funded under this topic shall include at least the following deliverables, but must not be limited to thoose: </span></span></span></p><ul level=\"0\"><li><span><span><span>Mapping public health evidence and research results on COVID-19 large-scale vaccination (point a above) - This should be a deliverable early in the project; </span></span></span></li><li><span><span><span>Implementation report from the pilot action (point D above);</span></span></span></li> </ul><p><span><span><span style=\"color:black\">S</span></span></span><span><span><span style=\"color:black\">ustainability plan for continued implementation and toolkits and recommendations for upscaling in other Member States (point E above)</span></span></span></p><p><strong><span><span><span style=\"color:black\">Specific action-level indicators for reporting purposes</span></span></span></strong></p><p><span><span><span style=\"color:black\">Applicants shall collect data on the following specific action-level indicators in their regular reporting activities in case of award:</span></span></span></p><ul level=\"0\"><li><span><span><span style=\"color:black\"> <span><span><span>Number of items (evidence and research results) mapped</span></span></span></span></span></span></li><li><span><span><span>Number of outcomes (analysis, reports, recommendations) produced on the basis of the information identified by the mapping</span></span></span></li><li><span><span><span>Number of Member States implementing solutions and recommendations produced on the basis of the information identified by the mapping</span></span></span></li><li><span><span><span>Number of implementation plans produced</span></span></span></li><li><span><span><span>Number of pilot activities initiated</span></span></span></li><li><span><span><span>Number of Member States participating to pilot activities</span></span></span></li><li><span><span><span>Number of pilot projects considered successful for upscaling</span></span></span></li><li><span><span><span>Number of sustainability plan, toolkits and recommendations for upscaling pilot projects in all MS</span></span></span></li><li><span><span><span>number of MS and/or Regions, which gave a commitment to the further implementation and uptake</span></span></span></li> </ul><p><span><span><span style=\"color:black\">The applicants are required to include in their proposals additional specific action-level indicators which will be agreed with the Commission during the grant agreement preparation. </span></span></span></p><p><span><span><span style=\"color:black\">The Commission may require the awardees to collect data for additional specific action-level indicators, where needed to complement the above indicators.</span></span></span></p>\n", "conditions": "<p><b><span style=\"font-size: 12pt; line-height: 18.4px; color: rgb(64, 64, 64);\" lang=\"EN-US\">Conditions<br />\r\n</span></b></p>\r\n<p><b><span style=\"color:#404040;mso-themecolor:&#xA;text1;mso-themetint:191;mso-ansi-language:EN-US\" lang=\"EN-US\">1.&nbsp;</span></b><b><span lang=\"EN-US\">Admissibility conditions: </span></b><span lang=\"EN-US\">described in section 5 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2022/call-fiche_eu4h-2022-pj_en.pdf\" target=\"_blank\">call document</a></span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2022/call-fiche_eu4h-2022-pj_en.pdf\" target=\"_blank\">&nbsp;</a></p>\n<p><b><span lang=\"EN-US\">Proposal page limits and layout:</span></b><span lang=\"EN-US\">&nbsp;described in Part B of the Application Form available in the Submission System</span></p>\n<p><b><span lang=\"EN-US\">2. Eligible countries:&nbsp;</span></b><span lang=\"EN-US\">described in section 6 of of the<a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2022/call-fiche_eu4h-2022-pj_en.pdf\" target=\"_blank\"> call document</a></span></p>\n<p><b><span lang=\"EN-US\">3. Other eligibility conditions:</span></b><span lang=\"EN-US\">&nbsp;described in section 6 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2022/call-fiche_eu4h-2022-pj_en.pdf\" target=\"_blank\">call document</a></span></p>\n<p><b>4. Financial and operational capacity and exclusion:&nbsp;</b>described in&nbsp;<span lang=\"EN-US\">section 7 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2022/call-fiche_eu4h-2022-pj_en.pdf\" target=\"_blank\">call document</a></span></p>\n<p><b><span lang=\"FR-BE\">5.&nbsp;Evaluation and award:</span></b></p>\n<ul>\r\n    <li><b><span lang=\"EN-US\">Award criteria, scoring and thresholds:</span></b><span lang=\"EN-US\">&nbsp;described in section 9 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2022/call-fiche_eu4h-2022-pj_en.pdf\" target=\"_blank\">call document</a></span></li>\r\n</ul>\n<ul>\r\n    <li><b><span style=\"color: rgb(64, 64, 64);\" lang=\"EN-US\">Submission and evaluation processes</span></b><b><span lang=\"EN-US\">:</span></b><span lang=\"EN-US\">&nbsp;described&nbsp;<span style=\"color: rgb(64, 64, 64);\">section 8 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2022/call-fiche_eu4h-2022-pj_en.pdf\" target=\"_blank\">call document</a> and the</span>&nbsp;</span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span lang=\"EN-US\">Online Manual</span></a></li>\r\n</ul>\n<ul>\r\n    <li><b><span lang=\"EN-US\">Indicative timeline for evaluation and grant agreement:&nbsp;</span></b><span lang=\"EN-US\">described in section 4 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2022/call-fiche_eu4h-2022-pj_en.pdf\" target=\"_blank\">call document</a></span></li>\r\n</ul>\n<p><b><span style=\"color: rgb(64, 64, 64);\" lang=\"EN-US\">6</span></b><b><span lang=\"EN-US\">. Legal and financial set-up of the grants:&nbsp;</span></b><span lang=\"EN-US\">described&nbsp;<span style=\"color: rgb(64, 64, 64);\">in section 10 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2022/call-fiche_eu4h-2022-pj_en.pdf\" target=\"_blank\">call document</a></span></span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><b><span style=\"font-size: 12pt; line-height: 18.4px; color: rgb(64, 64, 64);\" lang=\"EN-US\">Documents<br />\r\n<br />\r\n<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#xA;mso-ansi-language:EN-US\" lang=\"EN-US\"><b><span lang=\"EN-US\">Call documents:</span></b></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#xA;mso-ansi-language:EN-US\" lang=\"EN-US\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2022/call-fiche_eu4h-2022-pj_en.pdf\" target=\"_blank\">Call document </a><o:p></o:p></span></p>\r\n<p><strong>EU4health standard application form</strong>:&nbsp;<a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/temp-form/af/af_eu4h_en.pdf\" target=\"_blank\">Standard application form</a><br />\r\n<strong>EU4Health detailed budget</strong>:&nbsp;<a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/how-to-participate/reference-documents;programCode=EU4H\" target=\"_blank\">EU4Health Detailed budget table</a><br />\r\n<strong>EU4Health Programme</strong>:&nbsp;<a href=\"https://ec.europa.eu/health/funding/eu4health_en\" target=\"_blank\">EU4Health programme</a><br />\r\n<strong>EU4Health</strong>:&nbsp;<a href=\"https://ec.europa.eu/health/publications/2022-eu4health-work-programme_en\" target=\"_blank\">2022 Annual Work Programme</a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\">&nbsp;</p>\r\n<p>&nbsp;</p>\n<p><strong>EU4Health programme:</strong> <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/agr-contr/mga_eu4h_en.pdf\" target=\"_blank\">EU4Health&nbsp; MGA v1.0</a><br />\r\n<strong>EU4Health Regulation</strong>:  <a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021R0522\" target=\"_blank\">Regulation 2021/522</a><br />\r\n<strong>EU financial Regulation</strong>: <a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32018R1046&amp;qid=1535046024012\" target=\"_blank\">EU Financial Regulation 2018/1046</a></p>\r\n<p>&nbsp;</p>", "supportInfo": "<p><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">For help related to this</span><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">&nbsp;</span><b style=\"font-family: Arial, sans-serif; font-size: 9pt;\">call</b><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">, please contact:</span><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\"> </span>HaDEA-HP-CALLS@ec.europa.eu </p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq;grantAndTendertype=1;categories=p_submission_eval;programme=null;actions=;keyword=;period=null\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">Funding &amp; Tenders Portal FAQ</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Submission of proposals.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">IT Helpdesk</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Contact the IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://webgate.ec.europa.eu/funding-tenders-opportunities/display/OM/Online+Manual\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">Online Manual</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Step-by-step online guide through the Portal processes from proposal preparation and submission to reporting on your on-going project. Valid for all 2021-2027 programmes.</span></p>", "sepTemplate": "<p>To access the Electronic Submission Service, please click on the submission-button next to the <strong>type of action</strong> and the <strong>type of model grant agreement</strong> that corresponds to your proposal. You will then be asked to confirm your choice, as it cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.</p>", "links": [], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"additionalInfo": "", "staticAdditionalInfo": "", "latestInfos": [{"approvalDate": "Oct 26, 2022 11:41:37 AM", "lastChangeDate": "Oct 26, 2022 11:41:37 AM", "content": "<p class=\"MsoNormal\"><span style=\"font-size:10.5pt;line-height:115%;font-family:&#10;&quot;inherit&quot;,serif;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-bidi-font-family:&#10;Arial;color:#333333;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;&#10;padding:0cm;mso-ansi-language:EN-IE;mso-fareast-language:EN-IE\">A total of 41 </span><b><span style=\"font-size:10.5pt;line-height:115%;font-family:&quot;inherit&quot;,serif;&#10;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-bidi-font-family:Helvetica;&#10;color:#333333;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;&#10;padding:0cm;mso-ansi-language:EN-IE;mso-fareast-language:EN-IE\">proposals have been submitted&nbsp;</span></b><span style=\"font-size:10.5pt;line-height:115%;&#10;font-family:&quot;inherit&quot;,serif;mso-fareast-font-family:&quot;Times New Roman&quot;;&#10;mso-bidi-font-family:Arial;color:#333333;border:none windowtext 1.0pt;&#10;mso-border-alt:none windowtext 0cm;padding:0cm;mso-ansi-language:EN-IE;&#10;mso-fareast-language:EN-IE\">in response to this call.</span><span lang=\"EN-GB\"><o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2022-PJ-01: 6 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2022-PJ-02: 5 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2022-PJ-03: 6 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2022-PJ-04: 4 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2022-PJ-05: 1 proposal<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2022-PJ-06: 17 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2022-PJ-07: 1 proposal<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2022-PJ-08: 1 proposal<o:p></o:p></span></p>"}, {"approvalDate": "Feb 22, 2022 12:00:08 AM", "lastChangeDate": "Feb 22, 2022 12:00:08 AM", "content": "The submission session is now available for: EU4H-2022-PJ-06(EU4H-PJG), EU4H-2022-PJ-02(EU4H-PJG), EU4H-2022-PJ-03(EU4H-PJG), EU4H-2022-PJ-01(EU4H-PJG), EU4H-2022-PJ-05(EU4H-PJG), EU4H-2022-PJ-08(EU4H-PJG), EU4H-2022-PJ-04(EU4H-PJG), EU4H-2022-PJ-07(EU4H-PJG)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}